chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient complained of adverse effects including chills (with no fever), weakness, and being tired for 1 day after receiving the vaccine. She said she had it on day 1 of the series and also after the second shot on day 3, On day 1 she also received the IG immogam. Spoke with pharmacist and MD who both said to continue the series.
Severe chills about 11 hours after vaccine and body rash noticed more than 48 hours later.
swollen lymph in armpit breast; They ache randomly since this happened; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39-year-old female patient received BNT162b2 (BNT162B2), on 30Nov2021 at 12:30 as dose 3 (booster), single (Lot number: FJ1620) at the age of 39 years intramuscular, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Mood disorder" (unspecified if ongoing); "Migraines" (unspecified if ongoing), notes: Migraines. Concomitant medication(s) included: BUPROPION oral taken for affective disorder, start date: 2018 (ongoing); SUMATRIPTAN oral taken for migraine, start date: 2016 (ongoing). Vaccination history included: BNT162b2 (Dose:1st, Time: 10:30, Site and Route of injection:, Anatomical site of injection: Left arm, Route of administration: Intramuscular, Batch/Lot number: ER8737), administration date: 02Apr2021, for Covid-19 Immunization, reaction(s): "COVID-19"; BNT162b2 (Dose: 2nd, Time: 11:00, Site and Route of injection:, Anatomical site of injection: Left arm, Route of administration: Intramuscular, Batch/Lot number: EW0175), administration date: 23Apr2021, for Covid-19 Immunization, reaction(s): "COVID-19"; flucelvax (DOSE NUMBER UNKNOWN), administration date: 02Nov2021, for Immunization. The following information was reported: LYMPH NODE PAIN (non-serious) with onset 01Dec2021, outcome "unknown", described as "They ache randomly since this happened"; LYMPHADENOPATHY (non-serious) with onset 01Dec2021, outcome "recovering", described as "swollen lymph in armpit breast". The event "swollen lymph in armpit breast" required physician office visit. Therapeutic measures were not taken as a result of lymphadenopathy.  Additional Information: On day after booster vaccine (3 in the series), my lymph nodes in both armpits swelled. They ache randomly since this happened. Patient does not required the initiation of new medication/other treatment/procedure.
1st dose 2018, no 2nd dose yet; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 85-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included shingrix (1st dose received around 2018).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 06-FEB-2023 Reporter's comment: The reporter consented to follow up. The case was linked for case US2023018229, reported by same reporter for different patient. Additional supportive information: Till the time of reporting, the patient had not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination.; Sender's Comments:  US-GSK-US2023018229:Same reporter.
Became limp in mom's arms, eyes rolled back & perioral cyanosis noted; Lasted approx 35-40 secs; t104.9 in ER; gave mouth to mouth w/immed response;
1st dose of shingrix vaccine given to patient who is under 50 years old and is not immunocompromised.
Local reaction at injection site. Erythema, 8cm dia. Suspect allergic trigger.
Yesterday I noticed a large patch of red on my left arm extending of the site of the vaccination. It is warm to the touch
On 7/28/21, employee began feeling sick.   Symptoms were, nauseous,  vomiting, headache, fever,  body aches, coughing, shortness breath.   OTC medications are being taken.  No doctor or hospitalization to date.
I am 33 weeks pregnant today and I am due March 16th. I got my booster shot on the 8th of January. 13 days post booster shot / 3rd Moderna Vaccination I broke out in hives all over my face and body. Extremely itchy and burning. This has never happened to me before. The doctors at my Hospital, I am (Privacy), diagnosed me with Dermatographia. My face has cleared up however I am still experiencing the welts and itch everywhere else. You can write letters on my skin and they turn to welts. Every time I shower, use a pen, brush my flesh up against something, wash my hands I am left with welts.
a lot of weight gain; anxiety; nause; This spontaneous report has been received from an office manager via company representative referring to a current 21-year-old female patient of unknown age. The patient's concurrent condition, medical history and concomitant therapy information was not provided.      On an unknown date, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9), intramuscularly for prophylaxis (also reported as vaccination) (strength, dose, frequency, lot # and expiration date were not reported) as a teenager. It was unknown if the patient received treatment for the event. It was unknown whether laboratory diagnostics were performed.         On an unknown date, the patient experienced a lot of weight gain, anxiety, nausea, and she now only had 4 periods per year. The outcome of all events was not reported. The causality between all events and hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) was not provided.
Received AVA #4 on 3 Dec 07.  No problems with previous vaccinations.  Stated that he felt bad just after his shot and that symptoms worsened over the next several days.  He reported fever of 101-103, all joints painful, low back pain, headache and sore throat.  He went to the ER on 12 Dec 07 and they gave him fluids and antibiotics.  Currently he stated he is starting to feel better and he was told that he had a urinary tract infection.  Fever start - 12/04/2007, Joint pain, multiple joints start - 12/04/2007, Headache, general start - 12/04/2007, Pain start - 12/04/2007, Throat pain/sore throat.
Patient presented with wheezing and cough and was given Mucinex, PO steroid, Azithromycin and scheduled  Duonebs, symbicort.
Day after the 2nd shot at about 0930 got extreme shivers while taking a hot shower. By mid-afternoon had  a fever of 100-101. Flushed & shivery. Thereafter I have no recollection of the rest of the day till about 10:15 pm when my wife took me to bed. During the afternoon I called my sister & sent her a garbled text. I tried to talk to my wife but couldn't get the words out & didn't know  how to ask for what I wanted. I had a dazed look.  I have absolutely NO recollection of any of this. slept well that night. The next day Feb 27th I woke feeling largely improved, not feverish & still a bit heavy headed. But I was quite clumsy most of the day, dropping small items & bumping into things.
Tricep sore for 12 days, swollen upper arm for 10 days, took aleeve on day 10.  Swelling disappeared with aleeve, red itchy rash for 12 days.  Took benadryl and itchy rash disappeared.
Caller took her 2nd Pfizer vaccine on 04/07/21.  On yesterday (4/9/21), noted a red rash at the injection site.  Denies fever, or swelling, but does states it itches.  Instructed to apply cold compresses, and observe for further signs of increased redness or swelling and if present seek care from her PCP. PER RN.
sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-1901, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medications were reported.
Injection site soreness, chills, headaches,  nausea, diarrhea and vomiting
Patient reported to ED on 5/18/21 following second dose of COVID-19 Vaccine. Reported that around 9pm on the same day he received second vaccination developed the following symptoms: chills, body aches, back pain, knot in neck, sore throat. COVID test in ED on 5/18/21, negative.
I have diarrhea; This is a spontaneous report from a non-contactable consumer or other non hcp. A female patient of an unspecified age received BNT162B2, (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot #: was not reported), via an unspecified route of administration on an unspecified date as for covid-19 immunisation. Medical history included chemotherapy. Past drug included Imodium. Concomitant medications were not reported. On an unspecified date, it was reported that she had the Pfizer vaccine and had diarrhea. The patient asked could she take Imodium with the vaccine. Patient stated that she had diarrhea about once a month because she was on chemo and just take Imodium. Outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot been obtained.  .
I was pregnant when I received my vaccination.  I miscarried 11 days after I was vaccinated.  Since then, I have suffered two additional pregnancy losses, continuous menstrual disruptions,  spotting, and pelvic cramping for over one year.  Prior to being vaccinated, I did not have any of these symptoms reported to my OB and I also had a carried a prior healthy pregnancy to term before being vaccinated.   I am still suffering constant pelvic cramping and menstrual disruptions to this day.  All of these circumstances have robbed me of my ability to successfully carry a pregnancy and grow my family.
Fever (highest- 102.5 F), dizziness, muscle aches/soreness, chills, fatigue, chest pain, shortness of breath, muscle weakness, night sweats, vomiting, fainting
COVID sx (symptoms) after travel to (state-withheld) weekend of 29Apr2022; COVID sx (symptoms) after travel to (state-withheld) weekend of 29Apr2022; fever; chills; cold symptoms; This is a spontaneous report received from a non-contactable reporter(s) (Nurse).  A 33-year-old female patient (unknown if pregnant) received BNT162b2 (BNT162B2), on 28Jan2021 as dose 1, single (Lot number: EL3247), on 18Feb2021 as dose 2, single (Lot number: EL3247) and in Sep2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 32 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 02May2022, outcome "unknown" and all described as "COVID sx (symptoms) after travel to (state-withheld) weekend of 29Apr2022"; CHILLS (non-serious) with onset 02May2022, outcome "unknown"; NASOPHARYNGITIS (non-serious) with onset 02May2022, outcome "unknown", described as "cold symptoms"; PYREXIA (non-serious) with onset 02May2022, outcome "unknown", described as "fever". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (02May2022) Positive; (09May2022) Positive; (02May2022) Unknown results; (07May2022) Unknown results. It was unknown if therapeutic measures were taken as a result of covid-19, pyrexia, chills, nasopharyngitis.  Clinical course:adverse event :COVID sx (symptoms) after travel, weekend of 29Apr2022 then 02May2022 fever chills and cold symptoms and rapid Ag 02May2022 and 07May2022.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on the information available a possible contributory role of the suspect BNT162B2  cannot be excluded for the reported events of Covid-19 and drug ineffective.
Shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation referring to a female patient of unknown age. The patient's pertinent medical history, concurrent conditions or concomitant medications were not reported. In 2011, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot #, expiration date, dosage and route of administration were not provided) for the long-term prevention of shingles and/or zoster-related conditions. On an unspecified date, subsequent to the patient's vaccination with zoster vaccine live (ZOSTAVAX), the patient was treated by a physician for shingles. It was also specified that the patient had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The event shingles was considered to be related to zoster vaccine live (ZOSTAVAX) vaccination.
4/12/07 Generalized arthralgia, myalgia, rash noted on lower extremities, fatigue. 4/23/07 Symptoms begin to decrease 5/2/07 rash gone, myalgia/arthralgia gone - some fatigue and endurance remains.
Pt admitted to the ICU on 3/22/21 w/ pleuritic chest pain and shock requiring vasopressors. At time of admission pt had been taking antibiotics for an upper respiratory infection for 3 days. Echo Lv 40-45% upon admission. Pt was determined to have myopericarditis. On 3/24/21 pt was transferred to the cardiac intermediate unit. Endocrine consulted while in the cardiac intermediate unit to control his elevated blood sugars- endocrine team unable to determine if blood sugar is type 1 or type 2. on 3/27/21 pt went into respiratory distress required bipap & high flow nasal cannula and had a fever. Pulmonary consulted at this time- determined to be related to pulmonary edema and not a PE positive for pleural effusion. ID has been negative up to this point. 4/9/21 pt transferred to internal medicine service for work up for fever of unknown origin and continued management. Rheumatology consulted for leukocytosis, anemia, and elevated IgG. Ruled out connective tissue disease, stills disease, and vasculitis. Histoplasma was borderline positive pt has had recent bat exposure. Bone marrow biopsy done on 4/13/2021, ruled out HLH. Bronch done 4/15 to assess for TB, histoplasma, negative results so far. As of 4/15 no recommendations from ID and patient continues to look weaker/fatigued and spikes fever.
I did not have an adverse reaction to the vaccine. I had severe upper abdominal pain on the right side all day on 12/27/2023. I went to the emergency room for observation and was given nausea medicine and something for pain. I was referred to a gastroenterologist and was diagnosed with nonalcoholic fatty liver disease. As of today, I am feeling better.
4 days after my first pfizer shot I began experiencing pain and weakness in my hips and legs.  I was feeling fine during the day, normal exercise, and by nighttime I couldn't walk down my stairs and it has persisted ever since.  It's pain and discomfort in the front of my hips and down my legs causing weakness - walking is very difficult.  I have about 30% leg strength.
Site: Itching at Injection Site-Mild, Systemic: Allergic: Itch Generalized-Mild, Systemic: Allergic: Rash Generalized-Mild, Additional Details: Patient woke up the next morning with rash/hives and some itching.  Suggested that benedryl be given and if symptoms get worse to seek medical attention. Also made sure to let her know to keep an eye out on the reaction and to also give her primary MD a call once they open to let them know this occured and to see if any other medical measures need to be taken.
Had a sinus pressure, fatigue and chest congestion the 07/25/2021 and started taking Mucinex, sinus and Neti Pot, PCR test negative 08/01/2021. Test positive 08/06/2021 rapid test was contacted by her health department with directives for care and was contacted everyday during quarantine.
Information has been received from a company representative concerning a 15 month old patient, who in 1995, was vaccinated with a dose of varicella virus vaccine live (lot number unknown). The company representative heard from a certified midwife about the patient who in 1995 received the varicella virus vaccine live shot and two weeks later developed encephalitis, was hospitalized, and died two weeks later. It was noted this occurred at a different clinic than where the nurse midwife is currently working. It was noted the patient's gender was reported unknown (also reported as she). The cause of death was reported unknown. No additional information was provided. There was no product quality complaint reported. The encephalitis was considered to be immediately life threatening and disabling. Additional information has been requested. A 15-day follow report received 10/02/2003 adds: This is an amended report. The reporter has been changed, and the narrative has been updated to reflect the info. This report has been corrected as amended. Follow-up info was received, which reported that the certified nurse midwife, who was the original reporting source, indicated she had taken care of a mother, who tole her she had a child who received varicella virus vaccine live, experienced encephalitis and died two weeks later. The nurse midwife indicated she now worked at another practice and was unable to remember the name of the mother or the child. She did not know whether an autopsy had been done, and indicated that she had previously reported everything she knew. The case was considered closed, since no new info would be forth coming. The encephalitis was considered to be immediately life-threatening and disabling. A 15-day follow up report received 10/15/2003 adds no new info.  Follow up on 11/25/2003: "No further information is available, since the reporter no longer had access to the patient's records, nor could any details be remembered."
June 10 2021, I got up and I saw that my face was drooping. As the day progressed I saw that it was even worse so I went to the emergency room. I was diagnosed with Bell?s Palsy. I was prescribed steroids and antiviral medicine. It?s been a month and I am still unable to work. I look horrible. The pain of my neck head and face were unbearable.
Left ear is clogged (still to this day) and I have some hear loss as well as relentless tinnitus.    I was better off taking a chance with my own immune system instead of getting this vaccine.
Started with headache, nausea and chills. 24 hours after administration, shot site turned bright red and swollen. Hot to touch, the redness spread to about an 8 inch diameter circle. At this point had a fever of 100.1+. Unable to move arm, severe pain into arm pit and down to wrist. Saw doctor around 3:30pm on 9/21/10 prescribed Keflex thinking it was an infection. Fever, pain and redness continued for 10 more hours.
Painful / stabbing; itching; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles Shot with an associated reaction of herpes zoster (had older shot and got shingles after this).   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain and pruritus. On an unknown date, the outcome of the pain and pruritus were recovered/resolved.   It was unknown if the reporter considered the pain and pruritus to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The patient get the newer shingles vaccine shot dose and was painfull, Stabbing and Itching. This case has been linked with the case US2021AMR102061, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR102061:Same patient
16 yo male was given J&J vaccine.  After dose was given, a spread sheet of ages of immunized pts was done to determine numbers of individuals vaccinated by age range.  That is when it was discovered that a 16 year old was able to bypass the cut off in the system in some way.  Trying to replicate how that occurred has not been successful because the system will kick them out and not allow them to sign up.  Will follow up with the pt to figure out the error or how they were able to override the system and plan troubleshooting for future   events tomorrow. HCP giving vaccine
(L) arm redness about 8 cm diam, warmth that started 5 days post injection.
pt w/allergic rhinitis was vaxed w/MMR on 1APR85 & 23JUN85 pt devel petechiae on arms & legs; lab eval revealed hemoglobin 11.2, hematocrit 35, WBC 12,400, platelet count 8,500; repeat platelet count was 35,000 3MAY85; 19JUN85 195,000;
SWOLLEN ARM AROUND VACCINATION INJECTION SITE THAT SPREAD TO HIS UPPER ARM AND ARMPIT. PAIN AND SWELLING. LOSS OF TASTE. UPSET STOMACH.
No reaction give we gave a booster/3rd dose to a 15-year-old not realizing it was only approved for those who had medical conditions and on medication that cause the immune system to be compromised.  So this was given outside guidelines and protocol.  Required to report per company policy and immunization guidelines
Fever, vomiting, diarrhea x 3 days after dose of H1N1 vaccine.
stuttering 2 weeks after receiving the second dose; or inability to understand what a person is saying; This is a spontaneous report from a contactable consumer (Patient's wife). A 55-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration on an unspecified date as 2nd DOSE, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration on an unspecified date as single for covid-19 immunization. On an unspecified date the patient experienced stuttering 2 weeks after receiving the second dose, or inability to understand what a person is saying. The patient underwent lab tests and procedures which resulted normal- all test have come back normal. The outcome of events was unknown.  Follow up attempts are needed. Further information has been requested.
Pt  had chills night of vaccines, then dizzy, lightheaded morning after. Sat on toilet to gather himself but passed out to floor and hit his head. Ambulance took him to hospital for 2 days.